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Abstract: Species from the Montanoa genus have been used for hundreds of years in Mexican traditional medicine. The Náhuatl name 
given by Aztecs to this plant was “cihuapahtli”, meaning “woman’s medicine” (cihua, woman; pahtli, medicine), because M. tomentosa has 
been used to treat female health disorders since pre-Hispanic times due to its uterotonic properties. Later on, the Spanish pronunciation 
transformed the word into “zoapatle”, the name still used by herb sellers in México. Despite its use in folk medicine, intensive scientific 
research on this plant did not begin until the early 1970’s. The only two available reviews exclusively focused on the Montanoa species 
cover the period from 1529 to 1985. However, in the last two decades, important phytochemical, biochemical and biotechnological advances 
were achieved. This is a review of the history, botany, most relevant chemistry, biological activity and biotechnology of the secondary 
metabolites from the Montanoa genus so far. 
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Resumen: Especies del género Montanoa han sido empleadas por siglos en la medicina tradicional Mexicana. El nombre asignado a esta 
planta por los Aztecas fue “cihuapahtli”, ó “medicina para la mujer” (cihua, mujer; pahtli, medicina). Específicamente, M. tomentosa es 
usada para tratar desordenes de la mujer desde tiempos prehispánicos por sus propiedades uterotónicas. La castellanización transformó esta 
palabra en “zoapatle”, este nombre sigue siendo usado por los curanderos en México. A pesar de su uso en la medicina folklórica, la 
investigación científica intensa en esta planta comenzó desde inicios de 1970. Las únicas dos revisiones disponibles y dedicadas 
exclusivamente a las especies de Montanoa cubren el periodo de 1529 a 1985. Sin embargo, en las últimas dos décadas, se han logrado 
importantes avances fitoquímicos, bioquímicos y biotecnológicos. Este trabajo presenta una revisión de la historia, botánica, química más 
relevante, actividades biológicas y biotecnología de los metabolitos secundarios del género Montanoa a la fecha.  
 
Palabras clave: Etnobotánica, terpenoides, flavonoides, actividad-biólogica, Montanoa spp. 
 
Recibido | Received: July 1, 2013 
Aceptado en versión corregida | Accepted in revised form: September 3, 2014 
Publicado en línea | Published online: Septerber 30, 2014 
Declaración de intereses | Declaration of interests: This work was partially supported by a grant from ICGEB, Project CRP/MEX 04-03 Trieste, Italy; the grant CB2010-151144Z 
from CONACYT and by a postdoctoral fellowship to NVR from CONACYT México. 
Este artículo puede ser citado como / This article must be cited as: N Villa-Ruano, E Lozoya-Gloria. 2014. Anti-fertility and other biological activities of zoapatle (Montanoa 
spp.) with biotechnological application. Bol Latinoam Caribe Plant Med Aromat 13(5): 415 – 436.  
Villa-Ruano & Lozoya-Gloria.    Potential biotechnology of zoapatle (Montanoa spp.)  
 
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/416 
 
Occurrence, botanical description and 
ethnopharmacological background  
The Montanoa Cerv. genus belongs to the Asteraceae 
family within the Heliantheae tribe. This group is 
widely distributed in México and has also been found 
in Central America. Most of the known Mexican 
species are located in the states of Guanajuato, 
Guerrero, Hidalgo, Estado de México, Michoacán, 
Morelos, Nayarit, Nuevo León, Oaxaca, Puebla, 
Querétaro, San Luis Potosí, Tamaulipas, Tlaxcala and 
Veracruz (Plovanich & Panero, 2004). The botanist 
Vicente Cervantes named this genus Montanoa to 
honor Luis José Montaña (1775 - 1820), a prestigious 
medical doctor who used this plant to treat humans 
(Gallegos, 1983). Searches for members of the 
Asteraceae family and Montanoa genus in the 
International Plant Names Index revealed 185 
records, including 77 species (Appendix A) The 
morphological characterizations of the Montanoa 
spp. include capitula or heads with strongly 
conduplicate receptacular bracts and opposite, dentate 
and trinerve leaves. Common characteristics for the 
genus are sterile white ligules, white to yellow or, 
rarely, gray-black disc corollas, and accrescent pales 
that continue to grow and expand after anthesis, 
turning the flowering head into a spiny fruiting ball 
(Plovanich & Panero, 2004). Most species appear to 
flourish at relatively high elevations (1,650 to 2,500 
meters above sea level) where the climate range is 
temperate (0 to 35 °C). Although a chromosome 
number of X=19 is common, some polyploidy was 
reported for some species (Funk & Raven, 1980). The 
accompanying vegetation consists primarily of cacti, 
yuccas and other small shrubs (Levine et al., 1981). 
Plovanich & Panero (2004), detailed the phylogeny 
of 25 Montanoa species based on molecular markers. 
Their study contributed to a more accurate 
understanding of the phylogenetic relationships 
among Montanoa spp. within the Heliantheae tribe 
and complemented the previous morphological 
classification made (Funk, 1982).  
 Historically, the medicinal use of Montanoa 
spp. comes from Aztec healers who originally 
referred to this plant as “cihuapatli”, meaning 
“woman’s medicine” in Náhuatl (Alfaro, 1866). Due 
to Spanish influence, the word transformed into its 
current name of “zoapatle”. According to old pre-
Hispanic documents from the Aztecs, such as the 
“Florentine” and “de la Cruz-Badiano” codices, 
healers administered aqueous infusions of zoapatle to 
ease childbirth labor and to regulate the menstrual 
cycle in women (Lozoya, 1990). Ancient knowledge 
of zoapatle and other Mexican medicinal plants that 
were used as remedies for many disorders was first 
described in the “de la Cruz-Badiano codex” written 
in 1552, just 50 years after the Spanish conquest of 
Tenochtitlan. This codex was lost for 377 years, until 
1929, when it was found in the Vatican library. Pope 
John Paul II returned it to México on July 19, 1990, 
438 years after it was written. It is considered to be 
one of the most valuable documents of Aztec culture. 
It has not yet been totally deciphered, but active 
pharmacological properties have already been 
demonstrated for a dozen of the pre-Hispanic plants 
described. Among the most notable are the cihuapatli 
(Montanoa), some psychotropic plants like peyote 
(Lophophora) and toloache (Datura), the anti-
parasitic plant epazote (Chenopodium), and 
yolloxóchitl (Talauma), which has cardiotonic 
effects. It was written in Náhuatl by the Aztec 
medical doctor Martín de la Cruz, translated into 
Latin by Juan Badiano from Xochimilco, México and 
beautifully illustrated by tlacuilos (painters). It is the 
oldest medical document from the Americas. On the 
first page, the preface is dedicated to Francisco de 
Mendoza, formal son of Don Antonio de Mendoza, 
New Spain’s first Viceroy, because he ordered the 
elaboration of the document as a gift to the King of 
Spain. The king, however, never learned of the 
document, and, somehow, it arrived in the library of 
Diego de Contavila, a pharmacist from Madrid who 
lived until the mid-seventeenth century, shown by the 
written phrase ex-libris didaci Cortavila, which 
appears under the Francisco de Mendoza dedication. 
Later on, the nephew of Pope Urban VIII, Cardinal 
Barberini (1567 - 1679) acquired the document as 
shown by the note Barberini Latin 241. The codex 
ended up in the Vatican library, where it was 
abandoned and completely ignored until 1929, when 
it was re-discovered by the Latin teacher Charles U. 
Clark. This document has information on 
approximately 251 plants, 185 of which are 
illustrated. It has 13 chapters describing, principally, 
plants, minerals and animal products used by natives 
to heal diseases and ailments, divided into chapters as 
follows: Chapter I: Head remedies; Chapter II: Eye 
remedies; Chapter III: Hearing remedies; Chapter IV: 
Flu and cold remedies; Chapter V: Tooth and throat 
remedies; Chapter VI: Mouth and neck remedies; 
Chapter VII: Chest and stomach remedies; Chapter 
VIII: Bladder, buttocks, knee and foot remedies; 
Chapter IX: Black blood, fever and burn remedies; 
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Chapter X: Fear remedies; Chapter XI: Labor, 
menstruation and lactation remedies; Chapter XII: 
Children’s remedies; and Chapter XIII: Signs of 
impending death. The document finishes in folio 63 
with the inscription: In Tlaltelolco (a place in México 
City) in the Santa Cruz College, in the Santa María 
Magdalena fest and in the year of the reparation of 
the world of 1552 (Shein, 1993). 






Main volatile organic compounds reported for some members of the Montanoa genus. Sabinene (1), -
thujene (2), -pinene (3), -gurjunene (4), -caryophyllene (5), -cubebene (6) and valencene (7). 
 
 The codex, and other similar documents, 
motivated scientific inquiry and led to the beginning 
of formal phytochemical research projects. The first 
project targeting zoapatle (Caballero & Walls, 1970), 
was done during the 1980’s by the Mexican Institute 
for Social Security (IMSS), coupled with the General 
Coordination of the National Plan for Depressed 
Zones and Marginal Groups (COPLAMAR). They 
performed the most comprehensive ethnobotanical 
study ever conducted in México. The IMSS-
COPLAMAR program gathered information 
including the types, names and formal medical 
descriptions of sicknesses; the plants and other 
natural products used by healers to prepare the 
appropriate remedies; and their use and application in 
rural communities across México (Lozoya-Legorreta 
et al., 1988). Federal institutions were not alone in 
taking interest in the ancient patrimony of Mexican 
medicinal plants; private companies similarly 
considered the reports. The Ortho Corporation, which 
is owned by the Johnson & Johnson Company, began 
to focus on the Montanoa genus, particularly 
Montanoa tomentosa, the best-known representative 
from the genus, with an eye towards discovering new 
natural contraceptives. Of the 21 patents granted to 
the Ortho Corporation for the synthesis of single 
compounds and for the use of the decoction extract as 
a fertility control agent (Bejar et al., 2000), six 
patents (3,986,952, 3,996,132, 4,046,882, 4,060,604, 
4,112,078, and 4,237,053) were acquired between 
1976 and 1980 (Lozoya-Gloria, 2003).  
 From the early 1970’s to the first decade of 
the twenty-first century, the Montanoa genus has 
been the subject of phytochemical, pharmacological, 
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molecular and biotechnological studies, 
demonstrating its relevance in natural product 
research and its potential application in the medical, 
industrial and agro-alimentary fields. These aspects 





Representative germacradienolide sesquiterpene lactones from the Montanoa genus. Tomentosin (8), 
montafrusin A (9), montafrusin B (10), gigantanolides A (11), B (12) and C (13), leucanthanolide (14), 
leucanthanolide monoacetate (15) and 6-epi-deacetyllaurenobiolide (16). 
 
Chemical composition 
The most relevant compounds produced in Montanoa 
plants are terpenoids, mainly diterpenes but also 
including mono-, sesqui-, and triterpenoids as well as 
some interesting flavonoids. More than 70 
compounds have been characterized from this genus 
so far, but fascinatingly, these compounds were 
indirectly identified in studies conducted to isolate 
the bioactive substances involved in the herb’s 
uterotonic and contraceptive properties.  
 
Monoterpenoids and sesquiterpenoids 
Chemical profiles obtained by GC-MS and SPME-
GC-MS (solid-phase microextraction-gas 
chromatography-mass spectrometry), revealed an 
abundance of monoterpenoids such as sabinene (1), 
-thujene (2) and -pinene (3) (Compadre et al., 
1987; Robles-Zepeda et al., 2006). The most 
abundant sesquiterpenoids include -gurjunene (4), 
-caryophyllene (5), -cubebene (6) and valencene 
(7) in volatile fractions from mesophyll and glandular 
trichomes of M. tomentosa (Robles-Zepeda et al., 
2009) (Figure 1). Over 20 sesquiterpene lactones 
were originally characterized in this plant group, 
however, their heterogeneous structure confines their 
possible use as chemotaxonomical markers of the 
genus.The first sequiterpene lactone isolated from the 
zoapatle aerial parts was tomentosin (8) in 1971 
(Geissman and Griffin, 1971). Later on, the 
germacradienolide montafrusin A (9) and its 
analogue montafrusin B (10) were discovered in M. 
frutescens (Quijano et al., 1979; Quijano et al., 
1986). New germacradienolide skeletons were also 
sought in less-studied species, such as M. karwinskii 
(Quijano et al., 1995) or M. tomentosa subsp. 
xanthiifolia (Lidia-Pérez et al., 1994), the most being 
discovered from M. revealii, M. mollisima (Seaman 
et al., 1984a), M. guatemalensis, M. tomentosa subsp. 
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xanthiifolia (Castro & Jakupovic, 1985; Seaman et 
al., 1985), M. atriplicifolia (Bohlman et al., 1983), 
M. dumicola (Bohlman et al., 1984) and M. 
grandiflora (Quijano et al., 1984a ). Representatives 
of germacradienolide-type compounds isolated from 
theses species include the gigantanolides A (11), B 
(12) and C (13), found in organic extracts of M. gigas 
(Quijano et al., 1987), as well as leucanthanolide (14) 
and leucanthanolide monoacetate (15) which along 
with 6-epi-deacetyllaurenobiolide (16), were present 
in aerial parts of M. leucantha and M. hibiscifolia 




Heliangolide- and guaianolide-type sesquiterpene lactones from the Montanoa genus. Montacephalin (17), 
tomencephalin (18), 5-hydroxytomencephalin (19), and zoapatanolides A (20), B (21), C (22), D (23), E (24) 
and F (25). 
 Guaianolide and heliangolide sesquiterpene 
lactones were obtained from M. tomentosa subsp. 
xanthiifolia and M. tomentosa subsp. rosei (Seaman 
et al., 1984b), M. tomentosa subsp. microcephala 
(Topcu et al., 1988; Braca et al., 2001), and M. 
imbricate (Seaman et al., 1986). Montacephalin (17), 
tomencephalin (18), 5-hydroxytomencephalin (19) 
and zoapatanolides A (20), B (21), C (22), D (23), E 
(24) and F (25) (Quijano et al., 1982; Quijano et al., 
1984b; Quijano et al., 1985a; Quijano et al., 1991a) 
are incorporated in this group (Figure 3). 
Eudesmanolide-type sesquiterpene lactones in this 
genus, consist of the montafrusins C (26), D (27), E 
(28), F (29) (Quijano et al., 1985b) and 1, 2-dehydro-
3-oxocostic acid (30), (Seaman & Bencsath, 1985) 
from M. frutescens and M. speciosa, respectively. 
Novel members of this group were the dimeric 
eudesmanolide hydroxy-bis-dihydroencelin (31) 
(Quijano et al., 1991b), the antimycobacterial encelin 
(32), 1,2-dehydro-3-epi-isotelekin (33) (Sabanero et 
al., 1995), as well as unusual epoxyeudesmanolides 
with a rare endoperoxide structural element and rare 
carbonyl function such as 8-(2’,3’-epoxy-2’-
methylbutyryloxy)-4 -hydroxy-9-oxo-5H-eudesm-
1,11(13)-dien-6,12-olide (34) (Müller et al., 2004) 
(Figure 4). Montahibisciolides probably are the most 
innovative sesquiterpene lactones isolated from the 
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bisciolide (38) and 8-(2’,3’-epoxy-2’-methyl-
butyryloxy)-9-hydroxy-1-methoxy-1,10-
dihydromontahibisciolide) (39) which were originally 
found in M. hibiscifolia (Bohlmann et al., 1984) and 






Representative eudesmanolide sesquiterpene lactones from the Montanoa genus. Montafrusins C (26), D 
(27), E (28), F (29); 1,2-dehydro-3-oxocostic acid (30), hydroxy-bis-dihydroencelin (31), encelin (32), 1,2-




Zoapatanol (40) and montanol (41) were the first 
oxepane diterpenoids isolated from zoapatle in 1979 
(Levine et al., 1979). Chemical analysis of the non-
polar fraction of leaf extracts of M. tomentosa subsp. 
tomentosa lead to the isolation of tomexanthin (42) in 
1984 (Seaman et al., 1984c), tomexanthol (43) in 
1985 (Quijano et al., 1985c) and tomentanol (44) in 
1986 (Oshima et al., 1986b). Minor quantities of 38 
and 21-normontanol (45) were also discovered in 
organic extracts, but now, they are considered 
chemical artifacts produced from tomentol (46) 
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(Quijano et al.,1985c) and 40 (Marcelle et al., 1985), 
respectively. Pre-tomentol (47), pre-zoapatanol (48) 
and pre-tomexanthol (49) were also identified and 
later proposed to be the precursors of their respective 
final products (Quijano et al., 1985c) (Figure 6). In 
addition to this diterpenes synthetic derivatives with 
presumed contraceptive properties were developed 
(Taillier et al., 2004). The oxepane diterpenes have 
been detected only in Montanoa genus. This fact 
strongly suggests their specific biosynthesis in this 
genus, so they may be considered as taxonomical 
markers of this plant group. 
 Rigid tetracyclic diterpenoids are the most 
clinically studied compounds produced by these 
species. Kaurenal (50) (Castro & Jakupovic, 1985), 
kaurenoic acid (51) (Caballero & Walls, 1970), 16-
hydroxy-kaurenoic acid (52), 16-hydroxy-kaurenoic 
acid methyl ester (53), (Campos-Bedolla et al., 1997) 
grandifloric acid (15-hydroxy-kaurenoic acid) (54) 
(Campos-Bedolla et al., 1997), angeloyl grandifloric 
acid (55) (Quijano et al., 1994), cinnamoyl 
grandifloric acid (56) (Oshima et al., 1986a), 
grandiflorenic acid (57) (Caballero and Walls, 1970), 
12-hydroxy-grandiflorenic acid (58) (Quijano et al., 
1994), monoginoic acid (beyerenoic acid) (59), 
monoginol (60) (Gallegos, 1983) and the diterpene 
lactone zoapatlin (61) (Caballero & Walls, 1970) are 
considered valuable chemotaxonomical markers of 
both the Montanoa genus and the Asteraceae family 
(Figueiredo et al., 1995) (Figure 7). A synthetic 
derivative of 60, (±)-13-methoxy-15-oxozoapatlin 
(62), is the most well known antitumoral compound 
indirectly generated by the genus (Mi et al., 2002). 
More recently, evidence of non-early 13-
hydroxylated gibberellins, such as GA4 (63), was 
detected in young tissues of M. tomentosa plants 
(Villa-Ruano et al., 2009). 
 
Figure 5 
Some montahibisciolides isolated from the Montanoa genus. (8-Isobutyryloxy)-9-hydroxy-
montahibisciolide (35), 8-(2’-methylbutyryloxy)-9-hydroxy-montahibisciolide (36), 8-angeloyloxy-9-
hydroxy-montahibisciolide (37), 8-(2’,3’-epoxy-2’-methylbutyryloxy)-9-hydroxy-(11-13)-
dehydromontahibisciolide (38) and 8-(2’,3’-epoxy-2’-methylbutyryloxy)-9-hydroxy-1-methoxy-1,10-
dihydromontahibisciolide (39). 
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Non-polar extracts from M. gigas (Quijano et al., 
1987), M. leucantha (Quijano et al., 1994), M. 
tomentosa subsp. microcephala (Topcu et al., 1988; 
Braca et al., 2001), M. tomentosa subsp. xanthiifolia 
(Lidia-Pérez et al., 1994), M. karwinskii (Quijano et 
al., 1995), M. hibiscifolia and M. dumicola 
(Bohlmann et al., 1984) lead indirectly to the 
identification and isolation of known triterpenes such 
as -amyrin (64), -amyrin acetate (65), stigmasterol 
(66), stigmasterol 3-D-glucoside (67), -sitosterol 
(68), taraxasterol (69), taraxasterol acetate (70), and 
lupeol (71) (Figure 8).  
 
Flavonoids  
MeOH extracts obtained from M. tomentosa subsp. 
tomentosa (Oshima et al., 1986c) and petrol extracts 
from M. leucantha (Quijano et al., 1994) contained 
the glucoside-flavonoids nicotiflorin (kaempferol 3-
O-rutinoside) (72) and isoquercitrin (quercetin-3-
glucopyranoside) (73), and the aglycones 5,7,4’-
trihydroxy flavone (74), 3,7,4’-trimethoxy-5-
hydroxyflavone (75), 7,4’-dimethoxy-5-hydroxy-
flavone (76), 6,7,4’-trimethoxy-5-hydroxyflavone 
(77) and 6,7,8,4’-tetramethoxy-5-hydroxyflavone 





Oxepane diterpenes from the Montanoa genus. Zoapatanol (40), montanol (41), tomexanthin (42), 
tomexanthol (43), tomentanol (44), 21-normontanol (45), tomentol (46), pre-tomentol (47), pre-zoapatanol 




Currently, 5 is an FDA (Food and Drug 
Administration) approved food additive, representing 
the first dietary cannabinoid, as a known ingredient in 
pepper-based condiments. Antitumor and anti-
inflammatory effects have been reported for this 
compound (Gertsch et al., 2008).  
 Phytochemical research on the Montanoa 
genus has led to the discovery of a high number of 
these sesquiterpene lactones, but unfortunately, only 
a small percentage has been tested to determine their 
pharmacological or ecological properties. Although 8 
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was discovered in the early 1970’s (Geissman & 
Griffin 1971), its antineoplastic and antifungal 
properties were only recently revealed (Cafarchia et 
al., 2001). Compound 14 has no uterotonic effect, but 
have cytotoxic activity in the in vitro KB and P-388 
test systems (Oshima et al., 1986a). Compound 16 
from M. grandiflora has shown promising effects 
against Mycobacterium tuberculosis at relatively low 
concentrations (16 µg mL
-1
) (Cantrell et al., 2001). 
The guaianolides 17, 18, and 19, exhibit cytotoxic 
activity in the P-388 cell system (Topcu et al., 1988). 
The relationships in chemical structure between 
zoapatanolides (20-25) suggest that they could have 
analogous properties. To date, only compound 20 has 
been tested and found to be an inhibitor of uterine 
strips in vitro, nevertheless there is not any report on 
its presence in boiling aqueous solutions (Lu et al., 
1987). Antimycobacterial activity has been assigned 
for some eudesmanolides such as (33) and (34), 







Tetracyclic diterpenes from the Montanoa genus. Kaurenal (50), kaurenoic acid (51), 16α-hydroxy-kaurenoic 
acid (52), 16α-hydroxy-kaurenoic acid methyl ester (53), grandifloric acid (15α-hydroxy-kaurenoic acid) 
(54), angeloyl grandifloric acid (55), cinnamoyl grandifloric acid (56), grandiflorenic acid (57), 12-hydroxy-
grandiflorenic acid (58), monoginoic acid (beyerenoic acid) (59), monoginol (60), zoapatlin (61), (±)-13-
methoxy-15-oxozoapatlin (62) and GA4 (63). 
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 The montafrusins (26-29), which have the 
same skeleton type, and compound 30, have not been 
tested for this activity so far. 34 and similar 
compounds isolated from M. hibiscifolia showed 
effects on the inhibition of the transcription factor 
NF- (nuclear factor kappa-light-chain-enhancer of 
activated B cells) (Müller et al., 2004). Likewise, 
montahibisciolides as 36 inhibited the NF- 
transcription factor in Jurkat T and RAW 264.7 cells 
at low concentrations (10 µM) (Müller et al., 2004). 
Many other sesquiterpene lactones remain untested 
for biological activity, mainly because of their low 
endogenous concentrations, the availability of plant 
material year round, and a lack of improvements in 
extraction procedures (technical procedures). 
Unfortunately, many in vitro and especially, in vivo 
experiments using animal models require in many 
cases the order of grams to determine a possible 
biological activity. The dynamic biosynthesis of 
sesquiterpene lactones in the Montanoa genus 
predicts that interesting multifunctional enzymes that 






Triterpenoids and steroids from the Montanoa genus. β-amyrin (64), β-amyrin acetate (65),  
stigmasterol (66), stigmasterol 3β-D-glucoside, (68) β-sitosterol (67), taraxasterol (69), 
 taraxasterol acetate (70) and lupeol (71). 
 
Diterpenoids 
40 were believed to be the only diterpenoid involved 
in the uterotonic effects of zoapatle´s aqueous crude 
extracts (ZACE). However, Smith et al. (1981), 
demonstrated that the individual use of 40 had no 
significant effect in in vitro systems for a variety of 
animal species. Ponce-Monter et al. (1983), and Lu et 
al. (1987), observed the same results for 40, 41 and 
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42. Only a synthetic analog of 40, called ORF 13811, 
was confirmed to have a potent anti-fertility activity 
when orally administered to guinea pigs and other 
animals (Hahn et al., 1984). Despite these findings, 
other works proposed that 40 was the compound 
associated to pregnancy interruption and that 41, 42 
and 46 caused the inhibition of the spontaneous 
contraction of guinea pig uterine strips in vitro 
(Quijano et al., 1985c; Oshima et al., 1986b). 
Marcelle et al. (1985), demonstrated that free 
oxepane diterpenoids were sensitive to variations in 
light intensity and high temperature, causing 
alterations and even the complete destruction of their 
chemical structures. This study led to the 
development of efficient synthetic approaches to 
obtain oxepane diterpenoids, and modified 
derivatives, with anti-fertility properties (Hahn et al., 
1984; Taillier et al., 2004). The controversial results 
on the uterotonic properties of oxepane diterpenoids 
published for different authors around the world, is 
not yet resolved. On the other hand, the results of 
these phytochemical studies revealed very high 
abundance (≥ 0.03% dry weight) of oxepane 
diterpenoids in Montanoa plants suggesting that they 
possess ecological functions, probably as anti-
microbial or insecticidal agents. Nevertheless, these 




Flavonoids from the Montanoa genus. Nicotiflorin (kaempferol 3-O-rutinoside) (72), isoquercitrin 
(quercetin-3β-glucopyranoside) (73), 5,7,4’-trihydroxy flavone (74), 3,7,4’-trimethoxy-5-hydroxyflavone (75), 




Ponce-Monter et al. (1983), reported that 51 and 57 
(individually or mixed), reproduced the in vitro 
uterus contractility described by the oral 
administration of zoapatle decoctions. One year later, 
57 was confirmed as a potent uterine muscle 
stimulant in rats (Bejar et al., 1984). Interestingly, the 
activity of both 51 and 57 was highly reproducible in 
rats, guinea pigs, dogs, hamsters, monkeys (baboons 
and rhesus) and, even, humans (Gallegos, 1985). 
Additionally, the effect of some kaurane derivatives 
Villa-Ruano & Lozoya-Gloria.    Potential biotechnology of zoapatle (Montanoa spp.)  
 
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/426 
 
on human sperm motility was tested, but no 
significant effect was concluded (Valencia et 
al.,1986). Natural and synthetic kaurane-type 
diterpenoids were assayed, founding that 57 and its 
methyl ester induced uterine evacuation in vivo (Lu et 
al., 1987). Both 54 and 55 were found to be inhibitors 
of spontaneous uterine contractility (Lu et al., 1987; 
Campos-Bedolla et al., 1997). Compound 59 had no 
effect on rat uteri, but inhibited the electrically 
induced contraction of guinea-pig ilea (Zamilpa et 
al., 2002); however, spasmolytic as well as 
antimicrobial activities have been described for this 
diterpenoid (Zamilpa et al., 2002). Compounds 52 
and 53 presented similar inhibition effects on the 
uterus contractility of guinea pigs and rats induced by 
oxytocin, as previously described for 54 (Ponce-
Monter et al.,1988). The presence of 51, 57 and 59 in 
boiled decoctions was confirmed, demonstrating the 
high stability of the rigid tetracyclic diterpenoids, and 
providing scientific evidence on their involvement in 
the uterotonic phenomena described for ZACE in 
several animal species (Enríquez et al., 1996).  
 Compound 61 and synthetic derivatives such 
as 62 show potential as chemotherapeutic agents in 
HL-60, HUVEC (human umbilical vein endothelial 
cells), Ishikawa, KB, KB-V1, LNCaP, Lu1, MCF-7, 
Mel2, P-388, and SW626 cells (Mi et al., 2002). 
Natural occurring diterpenoids such as 51, 57 and 
their synthetic derivatives reveal a variety of effects 
as plant growth regulators and as antimicrobial, 
antiparasitic, insect antifeedant, cytotoxic, antitumor, 
anti-HIV, steroidogenic, antifertility, hypoglycemic, 
and embriotoxic agents (Ghisalberti, 1997; García et 
al., 2007). Despite kaurane-type diterpenoids are 
abundant in Montanoa plants, they are not 
exclusively limited in the genus, and other Asteraceae 
species actively produce this kind of molecules 
(García et al., 2007). Due to this fact, the botanical 
family represents in a general way a big source to 
obtain this diterpenoids.  
 
Triterpenoids 
Triterpenoids from Montanoa plants are associated 
with various pharmacological effects. Recently, the 
pentacyclic compounds 64 and 65 were found to 
possess antitubercular activity (Akihisa et al., 2005) 
and antifungal activity against Candida albicans 
(Johann et al., 2007). Compounds 64, 65 and 70 
demonstrated anti-inflammatory effects in different 
animal models (Pinto et al., 2008) and 66 and 68 
have shown antiviral activity (Khan et al., 1991). 
Phytosterols 67 and 68 decrease the risk of breast 
(Awad et al., 2000) and prostatic cancer (Wilt et al., 
1999). Compound 71 induces apoptosis of human 
pancreatic adenocarcinoma cells via the Ras signaling 
pathway, and possesses anti-arthritic and anti-
malarial properties (Murtaza et al., 2009). Compound 
69 and similar triterpenes reduced cholesterol levels 
in humans; these molecules have been included as 
chemopreventive anti-cancer additives in dietary 
supplements (Ovesná et al., 2004). Compound 69 is 
an inhibitor of the oxidative decomposition of 
polyunsaturated fatty acyl chains involved in some 
human pathologiesy (Gallová et al., 2007). 
Triterpenes found in high concentrations in 
Montanoa are clearly related with the stability of 
plant cell membranes, chemical composition of leaf 
waxes, adaptation to different temperatures and plant 
defense (Dufourc, 2008). 
 
Flavonoids 
Compound 72 is a novel and efficient neuroprotectant 
that has been used as an efficient agent against 
permanent focal cerebral ischemia induced in rats 
(Runping et al., 2006); it also appears to improve 
memory and to counteract oxidative stress (Huang et 
al., 2007). Compound 73 is an effective eosinophilic 
inflammation suppressor and its use has been 
proposed for the treatment of allergies (Rogerio et al., 
2007). Recently, this compound was associated with 
the reduction of glioblastomal cell proliferation 
(Amado et al., 2009). Compound 74, best known as 
apigenin, is an hypoglycemic agent and a strong 
inhibitor of Epstein-Barr virus (EBV) activation in 
Raji cells (Panda & Kar, 2007). Compound 76 is a 
key intermediary in the organic synthesis of 
robustaflavone, an anti-hepatitis B agent (Zembower 
& Zhang, 1998; Mooi et al., 2003).  
 
Biotechnology of M. tomentosa  
Volatile compounds identified in the Montanoa genus 
represent a rich source for industrial products because 
the essential oil of these plants contains high 
concentrations of 1, 2, 3 and 4. Compound 2 is the 
typical starting material from which 1-hydrate, a 
useful flavor component, is prepared. To prepare 2, 1 
is isomerized in the presence of 
ethylenediaminolithium. Volatiles 1, 2 and 4 are used 
in the creation and/or manufacturing of a diverse 
amount of exotic fragrances and flavor concentrates 
(Ferro & Naves, 1974). Compound 3 is commonly 
used as flavoring agent for baked goods and is also a 
Villa-Ruano & Lozoya-Gloria.    Potential biotechnology of zoapatle (Montanoa spp.)  
 
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/427 
 
common cosmetic ingredient. The use of 3 and 6 is 
approved for use in tobacco products as an additive 
or flavoring in several countries with Tobacco 
Product Regulations (Baker et al, 2004). Compound 
7 is a commercially available and inexpensive 
sesquiterpene hydrocarbon that can be 
biotransformed into its ketonic derivative nootkatone, 
which is one of the most important and valuable 
compounds in the cosmetic and fiber sectors 
(Furusawa et al., 2005). Compound 74 is a yellow 
crystalline solid that has been used to dye wool.  
 Compounds 51, 57 and 59 have been the 
subjects of biotechnological research due to their 
biological activities. Undifferentiated callus from M. 
tomentosa leaves and cell cultures from those 
calluses, grown in the presence of 2,4-
dichlorophenoxyacetic acid at 0.5 mg L
−1
 with kinetin 
at 2 mg L
−1
, showed an increased accumulation of the 
three diterpenoids up to 2.1 mg g
−1
 dry weight in 
callus and up to 0.76 mg g
−1 
in cell suspension 
cultures (Villarreal et al., 2001). Studies on the 
biosynthesis of these diterpenoids revealed the 
activity of a putative microsomal ent-kaurenoic-C9 
(11)-desaturase and a close relationship between 51 
and 57 (Villa-Ruano et al., 2009). The 
biotransformation of 51 by Rhizopus stolonifer 
fungus produces a desaturated ent-kaurane 9(11) 
similar to 57 (Silva et al., 1999), but this reaction had 
not been reported to occur in the plant itself until 
now. Involvement of 56 as precursor in the 
biosynthesis of physiologically active gibberellins 
(63 and GA4-like compounds), and the transformation 




pyrophosphate) as a substrate, proposed alternative 
biosynthetic pathways (Villa-Ruano et al., 2009). 
Currently, the M. tomentosa ent-kaurene oxidase 
cDNA has been isolated (Villa-Ruano et al., 2010). 
The identification, molecular cloning and 
heterologous expression of the coding DNA 
sequences involved in the biosynthesis of 
sesquiterpene lactones and diterpenes represent a 
novel biotechnological method for scaling up their 
production (Ro et al., 2008).  
 
CONCLUSIONS  
Research efforts to find natural contraceptives in 
Montanoa resulted in the identification of over 70 
compounds reported in the present review. Only 
some of these compounds showing pharmacological 
activities have recently been determined. The boiling 
aqueous solutions of M. tomentosa orally 
administered to induce childbirth, probably consist of 
a mix of different metabolites, but only the chemical 
stability of ent- kaurane diterpenoids was confirmed 
in these infusions (Enríquez et al., 1996). Therefore, 
this kind of diterpenoids should be strongly involved 
in zoapatle’s uterotonic effects. Montanoa genus as 
many other Asteraceae plants biosynthesizes high 
amounts of sesquiterpene lactones, nonetheless just a 
few showed relevant biological activityies. Unusual 
diterpenes, such as 40 and 61, were first characterized 
in this genus and now these molecules constitute 
classic models of organic synthesis (Taillier et al., 
2004) . Besides the sesqui- and diterpenes reported in 
zoapatle plants and their controversies regarding 
pharmacological activities (Rios et al., 2012), here 
we present other natural products biologically active 
like triterpenoids and flavonoids with putative 
biotechnological potential. Today the Montanoa 
genus is not only important in reproductive medicine, 
but its relevance has been extended to other areas of 
experimental biology such as cancer, immunological, 
pathological, and biotechnological research. 
However, there are still many other research areas to 
be developed. The specific action mechanisms and 
receptors for kaurenes in the smooth muscle of 
female mammals, as well as their effects in other 
physiological targets are still unknown. Although 
they have similar effects as the oxytocin peptide, 
their mechanisms seem to be quite different. Also, a 
report of M. tomentosa extract having aphrodisiac 
effects on male was published, but no more 
information on the putative active compounds 
involved in this activity has been reported since 2006 
(Carro-Juárez et al., 2006). Because of these reasons, 
zoapatle species have a privileged place among the 
medicinal plants of México and Central America. 
 Currently, the time required from initial 
clinical trials to FDA approval of a drug varies from 
6 - 11 years, and it can take 1 - 2 years more to 
receive the final decision at a cost of about $125 
million (Selected Regulations and Guidance for Drug 
Studies, 2011). Active Montanoa compounds have 
been used in humans for more than 200 years. 
However, other plant preparations have also been 
used, such as those illustrated in the Tepantitla mural 
found in Teothihuacán, the famous archaeological 
site just 30 miles northeast of México City. This site 
is believed to have been established around 100 BC. 
Some of the described plants have been used for 
more than 450 years in human beings (Ortiz de 
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Montellano, 1981). Ancient documents therefore 
represent a potentially rich information source for 
new medicinal natural substances.  
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Appendix A 
Records of Asteraceae family, Montanoa genus in the International Plant Names Index. 
 
Id Version Family Genus Authors 
136606-3 1.1 A M. Cerv. 
10111-1 1.3 A M. Cerv. 
894068-1 1.3 A M. ser. Amoenae V.A.Funk 
894069-1 1.3 A M. ser. Apertae V.A.Funk 
894070-1 1.3 A M. sect. Echinocephalae V.A.Funk 
894071-1 1.3 A M. ser. Frutescentes V.A.Funk 
894072-1 1.3 A M. ser. Grandiflorae V.A.Funk 
894073-1 1.3 A M. ser. Hibiscifoliae V.A.Funk 
894074-1 1.3 A M. ser. Intermediae V.A.Funk 
894075-1 1.3 A M. ser. Ovalifoliae V.A.Funk 
894076-1 1.3 A M. ser. Quadrangulares V.A.Funk 
163981-2 1.2 A M. affinis S.F.Blake 
233552-1 1.3 A M. affinis S.F.Blake 
233553-1 1.3 A M. andersonii McVaugh 
163982-2 1.2 A M. andersonii McVaugh 
163983-2 1.2 A M. angulata V.M.Badillo 
233554-1 1.1.2.1.1.1 A M. angulata V.M.Badillo 
233555-1 1.4 A M. anomala B.L.Rob. & Greenm. 
163984-2 1.1.2.1.1.1 A M. anomala B.L.Rob. & Greenm. 
281019-2 1.3 A M. arborescens DC. 
163985-2 1.3 A M. arborescens DC. 
233556-1 1.1.2.1 A M. arborescens K.Koch 
163986-2 1.2 A M. arsenei S.F.Blake 
233557-1 1.3 A M. arsenei S.F.Blake 
233558-1 1.1.2.2.1.1 A M. aschenbornii Sch.Bip. ex K.Koch 
163987-2 1.2 A M. aschenbornii Sch.Bip. 
233559-1 1.1.2.1 A M. atriplicifolia K.Koch 
163988-2 1.2 A M. atriplicifolia Sch.Bip. 
233560-1 1.3 A M. auriculata Cuatrec. 
163989-2 1.2 A M. auriculata Cuatrec. 
136630-3 1.2 A M. bipinnatifida (Kunth) K.Koch 
233561-1 1.1.2.1 A M. bipinnatifida K.Koch 
233562-1 1.1.2.1.1.1 A M. clematidea Hemsl. 
163971-2 1.2 A M. clematidea Walp. 
233563-1 1.1.2.2.1.1 A M. crenata Sch.Bip. ex K.Koch 
163990-2 1.2 A M. crenata Sch.Bip. 
233564-1 1.5 A M. dumicola Klatt ex T.Durand & Pitt. 
163991-2 1.2 A M. dumicola Klatt 
163992-2 1.2 A M. echinacea S.F.Blake 
233565-1 1.1.2.2 A M. echinacea S.F.Blake 
1167666-2 1.2 A M. elegans C.Koch 
233566-1 1.1.2.1 A M. elegans K.Koch 
163993-2 1.2 A M. elegans K.Koch 
163972-2 1.2 A M. ensifolia Sch.Bip. 
233567-1 1.1.2.1 A M. floribunda K.Koch 
163994-2 1.2 A M. fragrans V.M.Badillo 
233568-1 1.4 A M. fragrans V.M.Badillo 
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233569-1 1.1.2.1.1.1 A M. frutescens Hemsl. 
163995-2 1.4 A M. frutescens Mairet ex DC. 
233570-1 1.1.2.1.1.2 A M. gentryi S.F.Blake 
163996-2 1.2 A M. gentryi S.F.Blake 
163997-2 1.2 A M. gigas Rzed. 
233571-1 1.1.2.2.1.1 A M. gigas Rzed. 
163998-2 1.2 A M. gracilis Sch.Bip. 
233572-1 1.1.2.2.1.1 A M. gracilis Sch.Bip. ex K.Koch 
291565-2 1.2 A M. grandiflora Benth. 
233574-1 1.1.2.1.1.1 A M. grandiflora Hemsl. 
233573-1 1.1.2.1.1.1 A M. grandiflora Hemsl. 
233575-1 1.4 A M. guatemalensis B.L.Rob. & Greenm. 
163999-2 1.1.2.1.1.1 A M. guatemalensis B.L.Rob. & Greenm. 
233576-1 1.1.2.1.1.1 A M. hemsleyana S.F.Blake 
164000-2 1.2 A M. hemsleyana S.F.Blake 
233577-1 1.4 A M. heracleifolia Brongn. 
233578-1 1.1.2.1.1.1 A M. heterophylla Hemsl. 
164001-2 1.1.2.1.1.1 A M. hexagona B.L.Rob. & Greenm. 
233579-1 1.4 A M. hexagona B.L.Rob. & Greenm. 
233580-1 1.1.2.1 A M. hibiscifolia K.Koch 
163973-2 1.4.2.1 A M. hibiscifolia Benth. 
164003-2 1.3 A M. hibiscifolia (Benth.) D'Arcy 
233581-1 1.4 A M. hibiscifolia (Benth.) D'Arcy 
164002-2 1.4.2.1 A M. hibiscifolia Benth. 
136670-3 1.1 A M. hibiscifolia K.Koch 
900321-1 1.4 A M. imbricata V.A.Funk 
164004-2 1.2 A M. imbricata V.A.Funk 
900322-1 1.4 A M. josei V.A.Funk 
164005-2 1.2 A M. josei V.A.Funk 
163974-2 1.2 A M. karvinskii DC. 
233582-1 1.1.2.1 A M. karwinski K.Koch 
164006-2 1.2 A M. laskowskii McVaugh 
233583-1 1.3 A M. laskowskii McVaugh 
164007-2 1.2 A M. lehmannii S.F.Blake 
1085591-2 1.1.1.2 A M. lehmannii (Hieron.) S.F.Blake 
233584-1 1.1.2.1.1.1 A M. lehmannii S.F.Blake 
164008-2 1.2 A M. leucantha S.F.Blake 
233585-1 1.1.2.1.1.1 A M. leucantha S.F.Blake 
1034445-2 1.3 A M. leucantha (Lag.) S.F.Blake 
954941-1 1.2.2.1.1.1 A M. leucantha var. arborescens (DC.) B.L.Turner 
281020-2 1.3 A M. leucantha var. arborescens (DC.) B.L.Turner 
921188-1 1.5 A M. leucantha subsp. arborescens (DC.) V.A.Funk 
164009-2 1.3 A M. leucantha subsp. arborescens (DC.) V.A.Funk 
164010-2 1.2 A M. liebmannii S.F.Blake 
233586-1 1.1.2.1.1.3 A M. liebmannii S.F.Blake 
233587-1 1.4 A M. macrolepis B.L.Rob. & Greenm. 
164011-2 1.1.2.1.1.1 A M. macrolepis B.L.Rob. & Greenm. 
233588-1 1.1.2.2.1.1 A M. microcephala Sch.Bip. ex K.Koch 
164012-2 1.2 A M. microcephala Sch.Bip. 
281021-2 1.2 A M. microcephala Sch.Bip. 
164013-2 1.2 A M. mollissima Brongn. 
Villa-Ruano & Lozoya-Gloria.    Potential biotechnology of zoapatle (Montanoa spp.)  
 
Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/435 
 
233589-1 1.4 A M. mollissima Brongn. 
1058190-2 1.2 A M. moritziana Sch.Bip. 
164014-2 1.4 A M. moritziana Sch.Bip. in Kuntze 
233590-1 1.1.2.2.1.4 A M. moritziana Sch.Bip. Ex Kuntze 
233591-1 1.4 A M. myriocephala B.L.Rob. & Greenm. 
164015-2 1.1.2.1.1.1 A M. myriocephala B.L.Rob. & Greenm. 
164016-2 1.2 A M. olivae Sch.Bip. 
233592-1 1.1.2.2.1.1 A M. olivae Sch.Bip. ex K.Koch 
233593-1 1.2 A M. orbignyana Klatt 
233594-1 1.1.2.1 A M. ovalifolia K.Koch 
163975-2 1.2 A M. ovalifolia DC. 
164017-2 1.2 A M. ovalifolia subsp. australis V.A.Funk 
917115-1 1.5 A M. ovalifolia subsp. australis V.A.Funk 
164018-2 1.1.2.1 A M. palmeri Fernald 
233595-1 1.3 A M. palmeri Fernald 
233596-1 1.3 A M. patens A.Gray 
164019-2 1.2 A M. patens A.Gray 
233597-1 1.2 A M. pauciflora Klatt 
164020-2 1.2 A M. pauciflora Klatt 
233598-1 1.3 A M. pilosipalea S.F.Blake 
164021-2 1.2 A M. pilosipalea S.F.Blake 
164022-2 1.1.2.1.1.1 A M. pittieri B.L.Rob. & Greenm. 
233599-1 1.4 A M. pittieri B.L.Rob. & Greenm. 
164023-2 1.1.2.1.1.1 A M. pringlei B.L.Rob. & Greenm. 
233600-1 1.4 A M. pringlei B.L.Rob. & Greenm. 
164024-2 1.2 A M. pteropoda S.F.Blake 
233601-1 1.3 A M. pteropoda S.F.Blake 
233602-1 1.4 A M. purpurascens B.L.Rob. & Greenm. 
164025-2 1.1.2.1.1.1 A M. purpurascens B.L.Rob. & Greenm. 
233603-1 1.4 A M. purpurea Brongn. 
164026-2 1.2 A M. pyramidata Sch.Bip. 
233604-1 1.1.2.2.1.2 A M. pyramidata Sch.Bip. ex K.Koch 
233605-1 1.1.2.2.1.1 A M. quadrangularis Sch.Bip. ex K.Koch 
164027-2 1.2 A M. rekoi S.F.Blake 
233606-1 1.3 A M. rekoi S.F.Blake 
233607-1 1.1.2.2 A M. revealii H.Rob. 
164028-2 1.2 A M. revealii H.Rob. 
233608-1 1.4 A M. rosei B.L.Rob. & Greenm. 
164029-2 1.1.2.1.1.1 A M. rosei B.L.Rob. & Greenm. 
164030-2 1.2 A M. samalensis J.M.Coult. 
233609-1 1.2 A M. samalensis Coult 
164031-2 1.1.2.1.1.1 A M. schottii B.L.Rob. & Greenm. 
233610-1 1.4 A M. schottii B.L.Rob. & Greenm. 
164032-2 1.1.2.1.1.1 A M. seleriana B.L.Rob. & Greenm. 
233611-1 1.4 A M. seleriana B.L.Rob. & Greenm. 
233612-1 1.3 A M. serrata Rusby 
164033-2 1.2 A M. serrata Rusby 
233613-1 1.1.2.1 A M. speciosa K.Koch 
163976-2 1.2 A M. speciosa DC. 
900323-1 1.4 A M. standleyi V.A.Funk 
164034-2 1.2 A M. standleyi V.A.Funk 
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164035-2 1.2 A M. subglabra S.F.Blake 
233614-1 1.3 A M. subglabra S.F.Blake 
233615-1 1.4 A M. subtruncata A.Gray ex S.Watson 
164036-2 1.2 A M. subtruncata A.Gray 
164037-2 1.2 A M. tamayonis Aristeg. 
233616-1 1.3 A M. tamayonis Aristeg. 
164038-2 1.1.2.1 A M. tehuacana B.L.Rob. 
233617-1 1.4 A M. tehuacana B.L.Rob. 
233618-1 1.1.2.2.1.1 A M. ternifolia Sch.Bip. ex K.Koch 
164039-2 1.2 A M. ternifolia Sch.Bip. 
233619-1 1.1.2.1.1.3 A M. thomasii Klatt 
233620-1 1.3 A M. tomentosa Cerv. 
1183197-2 1.2 A M. tomentosa Cerv. 
164040-2 1.1.2.1.1.1 A M. tomentosa Cerv. 
163977-2 1.3 A M. tomentosa var. cordifolia DC. 
921189-1 1.4 A M. tomentosa subsp. microcephala (Sch.Bip.) V.A.Funk 
281023-2 1.3 A M. tomentosa var. microcephala (Sch.Bip.) B.L.Turner 
164041-2 1.3 A M. tomentosa subsp. microcephala (Sch.Bip.) V.A.Funk 
954940-1 1.1.2.1.1.4 A M. tomentosa var. microcephala (Sch.Bip.) B.L.Turner 
921190-1 1.1.2.1.1.2 A M. tomentosa subsp. rosei (Rose ex Robinson & Greenm.) 
V.A.Funk 
164042-2 1.1.2.1.1.2 A M. tomentosa subsp. rosei (B.L.Rob. & Greenm.) V.A.Funk 
163978-2 1.3 A M. tomentosa var. ternifolia DC. 
281022-2 1.3 A M. tomentosa var. xanthifolia (Sch.Bip.) B.L.Turner 
954939-1 1.1.2.1.1.4 A M. tomentosa var. xanthifolia (Sch.Bip.) B.L.Turner 
921191-1 1.4 A M. tomentosa subsp. xanthiifolia (Sch.Bip.) V.A.Funk 
164043-2 1.3 A M. tomentosa subsp. xanthiifolia (Sch.Bip.) V.A.Funk 
164044-2 1.2 A M. triloba Sch.Bip. 
233621-1 1.1.2.2.1.1 A M. triloba Sch.Bip. ex K.Koch 
163979-2 1.2 A M. trilobata Ram.Goyena 
233622-1 1.1.2.2.1.1 A M. uncinata Sch.Bip. ex K.Koch 
164045-2 1.2 A M. uncinata Sch.Bip. 
233623-1 1.3 A M. wercklei A.Berger 
164046-2 1.2 A M. wercklei A.Berger 
233624-1 1.1.2.2.1.1 A M. xanthiifolia Sch.Bip. ex K.Koch 
281024-2 1.2 A M. xanthiifolia Sch.Bip. 
164047-2 1.2 A M. xanthiifolia Sch.Bip. 
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